Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Liposomal Bupivacaine vs Standard Bupivacaine for Hypospadias Repair
NCT04479371Phase 1Withdrawn
- Sponsor
- UT Southwestern Medical Center
- Start
- Jul 2021
- Primary completion
- Jul 2022
- Modality
- Small Molecules
01
Overview
Phase 1, randomised, single-blind trial of bupivacaine in hypospadias (2 arms), sponsored by UT Southwestern Medical Center. Primary endpoint: Difference in Mean Pain Scores recorded over the first 72 hours following surgery. Planned start Jul 2021; status: withdrawn.
02
Drugs
bupivacaine
03
Conditions
hypospadias
Beyond the preview
Go deeper on NCT04479371.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04479371.